Agnieszka Krupa

ORCID: 0000-0003-1303-4608 · 1 paper in corpus

article 2023

Next step in the development of mesoprogestins: the preclinical profile of EC313

Frontiers in endocrinology ·doi:10.3389/fendo.2023.1201547

INTRODUCTION: The pharmacological target for progesterone, different progestins, and Selective Progesterone Receptor Modulators (SPRMs) is the nuclear progesterone receptor (PR). EC313 is a new member of a subgroup of SPRMs, mesoprogestins,…